Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders

Details for Australian Patent Application No. 2005262497 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Reitz, Allen B.; Maryanoff, Bruce E.; Parker, Michael N.; McComsey, David F.

Agent Shelston IP

Pub. Number AU-A-2005262497

PCT Pub. Number WO2006/007436

Priority 60/580,179 16.06.04 US

Filing date 16 June 2005

Wipo publication date 19 January 2006

International Classifications

C07D 321/08 (2006.01) Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups

A61K 31/353 (2006.01)

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

C07D 311/58 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 317/58 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 319/20 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/007436 Priority application(s): WO2006/007436

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005262499-Adhesive composition, method for bonding to a metal surface and rubber to metal adhesive

2005262496-Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders